Verition Fund Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,672
| Closed | -$305K | – | 2931 |
|
|
2024
Q4 | $305K | Buy |
28,672
+15,418
| +116% | +$164K | ﹤0.01% | 2139 |
|
|
2024
Q3 | $168K | Buy |
+13,254
| New | +$168K | ﹤0.01% | 2227 |
|
|
2023
Q4 | – | Sell |
-17,017
| Closed | -$238K | – | 2230 |
|
|
2023
Q3 | $238K | Buy |
+17,017
| New | +$238K | ﹤0.01% | 1542 |
|